Drug Shortage Report for CISPLATIN INJECTION, BP

Last updated on 2017-04-06 History
Report ID 3275
Drug Identification Number 02355183
Brand name CISPLATIN INJECTION, BP
Common or Proper name CISPLATIN
Company Name ACCORD HEALTHCARE INC
Active Ingredient(s) CISPLATIN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100 ML VIAL OF 100 MG | FLACON DE 100 ML DE 100 MG
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-03-06
Actual start date 2017-03-06
Estimated end date 2017-04-12
Actual end date 2017-03-30
Shortage status Resolved
Updated date 2017-04-06
Company comments
Health Canada comments
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-04-06 English Compare
v4 2017-03-17 French Compare
v3 2017-03-17 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare